文献速递骨质疏松与代谢性骨病

在骨折风险增高的骨质疏松患者中,药物治疗基础上增加运动或体力活动能否改善骨密度并降低骨折风险?系统综述与Meta分析

Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2023-07-11

该系统综述与Meta分析纳入5项随机对照试验共530例患者,比较运动联合药物治疗与单纯药物治疗对骨密度、骨转换标志物、骨折愈合和骨折的影响。Meta分析显示,12个月时运动联合药物组在髋部、胫骨、腰椎和前臂的骨密度效应量较大,但证据确定性极低且置信区间宽,股骨颈无改善,骨转换标志物也无改善。尚无骨折愈合或骨折结局数据,运动是否对药物治疗有附加影响仍不明确。

要点

  • 运动联合药物与单纯药物相比,12个月时髋部、胫骨、腰椎和前臂骨密度效应量较大,但证据确定性极低。
  • 股骨颈骨密度未见改善(SMD -0.03 [-1.80; 1.75],n=3)。
  • 骨转换标志物如骨碱性磷酸酶、PINP和CTX-I未见改善,置信区间非常宽。

核心结论

  • 运动是否对骨质疏松患者的药物治疗具有附加影响仍不明确。
  • 需要高质量、有足够把握度、针对性的随机对照试验。

研究设计与样本

  • 前瞻性注册的系统综述与Meta分析,检索4个数据库(建库至2022年5月6日)、5个试验注册库和参考文献列表。
  • 纳入比较运动联合药物治疗与单纯药物治疗对骨密度、骨转换标志物、骨折愈合和骨折影响的随机对照试验。
  • 从2593条记录中纳入5项随机对照试验共530例参与者。
  • 使用Cochrane RoB2评估偏倚风险,采用GRADE方法评估证据确定性。
  • 采用Hartung-Knapp-Sidik-Jonkman校正的随机效应Meta分析估计标准化均数差和95%置信区间。

主要发现

  • 12个月时,运动联合药物组相比单纯药物组在髋部骨密度的效应量较大(SMD 0.18 [-1.71; 2.06],n=3项研究),证据确定性极低且置信区间宽。
  • 12个月时,运动联合药物组相比单纯药物组在胫骨骨密度的效应量较大(SMD 0.25 [-4.85; 5.34],n=2项研究)。
  • 12个月时,运动联合药物组相比单纯药物组在腰椎骨密度的效应量较大(SMD 0.20 [-1.15; 1.55],n=4项研究)。
  • 12个月时,运动联合药物组相比单纯药物组在前臂骨密度的效应量较大(SMD 0.05 [-0.35; 0.46],n=3项研究)。
  • 12个月时,运动联合药物组相比单纯药物组在股骨颈骨密度未见改善(SMD -0.03 [-1.80; 1.75],n=3项研究)。

关键数值与推荐

  • 骨转换标志物骨碱性磷酸酶未见改善(SMD -0.68 [-5.88; 4.53],n=3项研究),置信区间非常宽。
  • 骨转换标志物PINP未见改善(SMD -0.74 [-10.42; 8.93],n=2项研究),置信区间非常宽。
  • 骨转换标志物CTX-I未见改善(SMD -0.69 [-9.61; 8.23],n=2项研究),置信区间非常宽。
  • 通过注册库识别出3项可能相关的正在进行的试验。
  • 未发现骨折愈合或骨折结局的数据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据确定性极低且置信区间宽。
  • 骨转换标志物的置信区间非常宽。
  • 未发现骨折愈合或骨折结局的数据。
  • 运动是否对药物治疗具有附加影响仍不明确。
  • 需要高质量、有足够把握度、针对性的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This prospectively registered systematic review and meta-analysis examines whether exercise (EX) training has an additive effect to osteoanabolic and/or antiresorptive pharmacological therapy (PT) in people with osteoporosis on bone mineral density (BMD), bone turnover markers (BTMs), fracture healing, and fractures. Four databases (inception to 6 May 2022), 5 trial registries, and reference lists were searched. Included were randomized controlled trials comparing the effect of EX + PT vs. PT with regard to BMD, BTM, fracture healing, and fractures. Risk of bias was assessed using the Cochrane RoB2 and certainty of evidence by the GRADE approach. Random-effects meta-analysis with Hartung-Knapp-Sidik-Jonkman adjustment was used to estimate standardized mean differences and 95% confidence intervals. Out of 2593 records, five RCTs with 530 participants were included. Meta-analysis showed with very low certainty evidence and wide confidence intervals that EX + PT compared to PT had larger effect sizes for BMD at 12 months at the hip (SMD [95%CI]: 0.18 [- 1.71; 2.06], n = 3 studies), tibia (0.25 [- 4.85; 5.34], n = 2), lumbar spine (0.20 [- 1.15; 1.55], n = 4), and forearm (0.05 [- 0.35; 0.46], n = 3), but not femoral neck (- 0.03 [- 1.80; 1.75], n = 3). Furthermore, no improvement was revealed for BTM such as bone ALP (- 0.68 [- 5.88; 4.53], n = 3), PINP (- 0.74 [- 10.42; 8.93], n = 2), and CTX-I (- 0.69 [- 9.61; 8.23], n = 2), but with very wide confidence intervals. Three potentially relevant ongoing trials were identified via registries. No data were found for fracture healing or fracture outcomes. It remains unclear whether EX has an additive impact to PT in people with osteoporosis. High-quality, adequately powered, targetted RCTs are required. PROTOCOL REGISTRATION: PROSPERO CRD42022336132.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Schumm AK, Craige EA, Arora NK, et al. Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis. Osteoporos Int. 2023. PMID: 37430002. doi:10.1007/s00198-023-06829-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。